InvestorsObserver
×
News Home

Will F-Star Therapeutics Inc (FSTX) Stay at the Top of the Healthcare Sector?

Wednesday, November 24, 2021 01:24 PM | InvestorsObserver Analysts

Mentioned in this article

Will F-Star Therapeutics Inc (FSTX) Stay at the Top of the Healthcare Sector?

The 27 rating InvestorsObserver gives to F-Star Therapeutics Inc (FSTX) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 79 percent of stocks in the Healthcare sector, FSTX’s 27 overall rating means the stock scores better than 27 of all stocks.

Overall Score - 27
FSTX has an Overall Score of 27. Find out what this means to you and get the rest of the rankings on FSTX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With F-Star Therapeutics Inc Stock Today?

F-Star Therapeutics Inc (FSTX) stock is trading at $5.63 as of 1:23 PM on Wednesday, Nov 24, a rise of $0.28, or 5.23% from the previous closing price of $5.35. The stock has traded between $5.23 and $5.70 so far today. Volume today is below average. So far 191,813 shares have traded compared to average volume of 359,926 shares. Click Here to get the full Stock Report for F-Star Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App